AMY MULCAHY: Open Payments
NPI 1689785321 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 9 payments from 7 companies in 2025. Trend: 2023 $150 · 2024 $166 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $63 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $36 |
| Boston Scientific Corporation | 1 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Kestra Medical Technology Services, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: Kerendia, LifeVest, WATCHMAN FLX, AMVUTTRA, Assure WCD, LOKELMA, JARDIANCE.
Industry payments across IN — which companies pay providers there.
